Conflict, displacement, and climate-driven droughts continue to hinder health access and control of vaccine-preventable diseases in the region ...

French biotech Valneva has secured marketing approval in the UK for its chikungunya vaccine, Ixchiq (chikungunya vaccine), ...

In this review, we focus on the cost-effectiveness of varicella vaccination and on the methodology used in the health-economic studies. In particular, we focus on the perspective adopted ...

Bavarian Nordic is now catching up to Valneva, whose Ixchiq vaccine became the world’s first licensed chikungunya vaccine when it was approved by the US Food and Drug Administration (FDA) in November ...

Saint Herblain (France), January 30, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the signing of a new $32.8 million contract with the ...

Ixchiq Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 The Business Research Company’s Ixchiq Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 Updated 20 ...

What Are The Emerging Trends In The ixchiq Market? Key trends emerging in the Ixchiq market include the development of a chikungunya vaccine. A notable instance is Valneva SE, a France-based ...

Key trends emerging in the Ixchiq market include the development of a chikungunya vaccine. A notable instance is Valneva SE, a France-based biotechnology company, who received marketing ...

Netflix Inc. is raising prices again — though for some viewers, it’s actually been some time since the last hike. The company announced alongside its earnings Tuesday afternoon that it will be ...